Drug Profile
LYP 010
Alternative Names: LYP-010Latest Information Update: 04 Nov 2017
Price :
$50
*
At a glance
- Originator Lypanosys
- Class Skin disorder therapies
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Atopic dermatitis
Most Recent Events
- 04 Nov 2017 No recent reports of development identified for clinical-Phase-Unknown development in Atopic-dermatitis in USA (PO, Capsule)
- 05 Mar 2014 Clinical trials in Atopic dermatitis in USA (PO)